Evidence-Based Colorectal Cancer Screening for the Uninsured

NCT01946282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8565

Last updated 2020-03-19

Study results available
· View outcomes & findings →

Summary

Through this program, the investigators will test a systematic colon cancer screening outreach strategy for increasing screening completion among uninsured patients, not up-to-date with screening. The intervention will consist of mailed screening invitations, with processes such as phone reminders to promote screening and evidence based follow up. All patients will be randomly assigned to receive mailed invitations to complete a home fecal immunochemical test (FIT). Some patients will be randomly assigned to receive a small financial incentive on completion of FIT testing.

Conditions

Interventions

OTHER

FIT Invitation Only

Patients meeting the inclusion / exclusion criteria are mailed invitations to complete a free colorectal cancer screening. POLYMEDCO Fecal Immunochemical Tests (FIT) are mailed to patient homes with instructions, followed up with live and TELEVOX reminder phone calls.

OTHER

FIT plus $5 Incentive

Patients meeting the inclusion / exclusion criteria are mailed invitations to complete a free colorectal cancer screening. POLYMEDCO Fecal Immunochemical Tests (FIT) are mailed to patient homes with instructions, followed up with live and TELEVOX reminder phone calls. Patients are offered a small incentive to complete their screening.

OTHER

FIT plus $10 Incentive

Patients meeting the inclusion / exclusion criteria are mailed invitations to complete a free colorectal cancer screening. POLYMEDCO Fecal Immunochemical Tests (FIT) are mailed to patient homes with instructions, followed up with live and TELEVOX reminder phone calls. Patients are offered a small incentive to complete their screening.

Sponsors & Collaborators

  • Cancer Prevention Research Institute of Texas

    collaborator OTHER
  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Keith Argenbright, M.D. · UT Southwestern Medical Center

  • Samir Gupta, M.D. · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-04-30
Completion
2017-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946282 on ClinicalTrials.gov